Abstract
Six patients with multiple myeloma and chronic renal insufficiency (serum creatinine >3.0 mg/dl), including four on dialysis, received high-dose busulfan and cyclophosphamide (BUCY) followed by autologous peripheral stem cell transplantation. Peripheral blood stem cells were collected after priming with cyclophosphamide, etoposide and G-CSF. Patterns of engraftment and toxicities were not apparently different from those seen in myeloma patients with normal renal function. There was one toxicity-related death, resulting from a massive spontaneous subdural hematoma. One patient died of disease progression 6 months after transplant, while the remaining four patients are alive and free of myeloma progression 6 to 39 months after high-dose therapy. Two of these patients have remained in complete remission for 28 and 39 months. Our experience suggests that high-dose therapy with BUCY and autologous peripheral blood stem cell rescue is feasible in patients with multiple myeloma and renal failure.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ballester, O., Tummala, R., Janssen, W. et al. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency. Bone Marrow Transplant 20, 653–656 (1997). https://doi.org/10.1038/sj.bmt.1700950
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700950
Keywords
This article is cited by
-
Extending autologous transplantation as first line therapy in multiple myeloma patients with severe renal impairment: a retrospective study by the SFGM-TC
Bone Marrow Transplantation (2018)
-
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
Bone Marrow Transplantation (2015)
-
Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?
Bone Marrow Transplantation (2013)
-
Renal failure in multiple myeloma: a medical emergency
Bone Marrow Transplantation (2011)
-
Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine
Bone Marrow Transplantation (2010)